New pill takes on tough cancers in first human test
Disease control
Recruiting now
This early-stage trial tests an experimental oral drug called CID-078 in 220 adults with advanced solid tumors that have not responded to standard treatments. The study is split into two parts: first, finding a safe dose, and then checking if the drug shrinks tumors. It is a firs…
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC